These findings identify a keratinocyte‐intrinsic mechanism by which FADS2 restrains psoriatic inflammation, highlighting the PPARα‐FADS2 axis as a potential therapeutic target for psoriasis. This evidence concerns the gene FADS2 and psoriasis.